Fundz

Vittoria Biotherapeutics Secures Over $15 Million In Private Financing Round To Support The Development Of Novel Car-T Cell Therapies

PRIVATENov 14, 2023

Amount Raised

$15 Million

Round Type

Funding Round

PhiladelphiaManufacturingBiotechnologyHealth CareTherapeutics

Description

Vittoria Biotherapeutics today announced it has secured over $15 million in a private financing round. The funds will be used to continue advancing Vittoria’s lead candidate, VIPER-101, an autologous, dual population CD5-knockout CAR-T cell therapy for T-cell Lymphoma, into the clinic. VIPER-101 features the Company’s novel Senza5Ô platform technology.

Quick answer

Vittoria raised $15 Million in a Funding Round round, dated November 14, 2023. Vittoria is based in Philadelphia, Pennsylvania, United States.

How much did Vittoria raise?
Vittoria raised $15 Million in a Funding Round round on November 14, 2023.
What does Vittoria do?
Vittoria Biotherapeutics is a clinical-stage cell therapy company dedicated to developing innovative cell therapies for various diseases, with a focus on T-cell lymphoma.
Where is Vittoria based and how big is it?
Vittoria is based in Philadelphia, Pennsylvania, United States.
Who are the decision-makers at Vittoria?
Fundz holds 1 contact at Vittoria. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Manufacturing around the same time

Companies in the same sectors as Vittoria that raised within 45 days of this round, from Fundz verified event records.

  • Gyre Therapeutics raised $5M on October 30, 2023.
  • Alpha Cognition raised $1.8M (Seed) on December 22, 2023.
  • Novabay raised $555K (Seed) on December 21, 2023.
  • Cadenza Bio raised an undisclosed amount (Funding Round) on December 20, 2023.
  • Sudo Biosciences raised $116M (Series B) on December 20, 2023.
  • Allurion Technologies raised $123K (Pre-Seed) on December 18, 2023.

Who to call at Vittoria, and when

A new round usually means Vittoria is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vittoria raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vittoria, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vittoria. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vittoria

Location

Philadelphia, Pennsylvania, United States

About

Vittoria Biotherapeutics is a clinical-stage cell therapy company dedicated to developing innovative cell therapies for various diseases, with a focus on T-cell lymphoma. The company's proprietary Senza5 platform combines genetic engineering and a five-day manufacturing process to maximize the stemness, durability, and efficacy of its cell therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vittoria raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Vittoria's next move

See what Strategic adds

Vittoria raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.